BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 11198287)

  • 1. Hypocretin deficiency in familial symptomatic narcolepsy.
    Melberg A; Ripley B; Lin L; Hetta J; Mignot E; Nishino S
    Ann Neurol; 2001 Jan; 49(1):136-7. PubMed ID: 11198287
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypocretin levels in sporadic and familial cases of canine narcolepsy.
    Ripley B; Fujiki N; Okura M; Mignot E; Nishino S
    Neurobiol Dis; 2001 Jun; 8(3):525-34. PubMed ID: 11442359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The level of hypocretin 1 (orexin A) in cerebrospinal fluid and the diagnosis of narcolepsy and other somnolent disorders.
    Kunimoto M
    Intern Med; 2003 Aug; 42(8):634-5. PubMed ID: 12924483
    [No Abstract]   [Full Text] [Related]  

  • 4. Undetectable levels of CSF hypocretin-1 (orexin-A) in two prepubertal boys with narcolepsy.
    Tsukamoto H; Ishikawa T; Fujii Y; Fukumizu M; Sugai K; Kanbayashi T
    Neuropediatrics; 2002 Feb; 33(1):51-2. PubMed ID: 11930279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low cerebrospinal fluid hypocretin (orexin) and altered energy homeostasis in human narcolepsy.
    Schuld A; Blum WF; Pollmächer T
    Ann Neurol; 2002 May; 51(5):660; author reply 660-1. PubMed ID: 12112120
    [No Abstract]   [Full Text] [Related]  

  • 6. On the value of measuring CSF hypocretin-1 in diagnosing narcolepsy.
    Mignot E; Chen W; Black J
    Sleep; 2003 Sep; 26(6):646-9. PubMed ID: 14572113
    [No Abstract]   [Full Text] [Related]  

  • 7. Hypocretin (orexin) deficiency in human narcolepsy.
    Nishino S; Ripley B; Overeem S; Lammers GJ; Mignot E
    Lancet; 2000 Jan; 355(9197):39-40. PubMed ID: 10615891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monozygotic twins concordant for narcolepsy-cataplexy without any detectable abnormality in the hypocretin (orexin) pathway.
    Khatami R; Maret S; Werth E; Rétey J; Schmid D; Maly F; Tafti M; Bassetti CL
    Lancet; 2004 Apr; 363(9416):1199-200. PubMed ID: 15081654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypocretin (orexin) deficiency in narcolepsy-cataplexy].
    Nevsímalová S; Vanková J; Sonka K; Faraco J; Rogers W; Overeem S; Mignot E
    Sb Lek; 2000; 101(4):381-6. PubMed ID: 11702580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solving the mysteries of narcolepsy: the hypocretin story.
    Silber MH; Rye DB
    Neurology; 2001 Jun; 56(12):1616-8. PubMed ID: 11425923
    [No Abstract]   [Full Text] [Related]  

  • 11. Undetectable CSF level of orexin A (hypocretin-1) in a HLA-DR2 negative patient with narcolepsy-cataplexy.
    Dalal MA; Schuld A; Pollmächer T
    J Sleep Res; 2002 Sep; 11(3):273. PubMed ID: 12220324
    [No Abstract]   [Full Text] [Related]  

  • 12. Normal plasma levels of orexin A (hypocretin-1) in narcoleptic patients.
    Dalal MA; Schuld A; Haack M; Uhr M; Geisler P; Eisensehr I; Noachtar S; Pollmächer T
    Neurology; 2001 Jun; 56(12):1749-51. PubMed ID: 11425946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CSF hypocretin-1 (orexin-A) concentrations in narcolepsy with and without cataplexy and idiopathic hypersomnia.
    Kanbayashi T; Inoue Y; Chiba S; Aizawa R; Saito Y; Tsukamoto H; Fujii Y; Nishino S; Shimizu T
    J Sleep Res; 2002 Mar; 11(1):91-3. PubMed ID: 11869432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinson's disease comorbid with narcolepsy presenting low CSF hypocretin/orexin level.
    Maeda T; Nagata K; Kondo H; Kanbayashi T
    Sleep Med; 2006 Dec; 7(8):662. PubMed ID: 17097921
    [No Abstract]   [Full Text] [Related]  

  • 15. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
    Nishino S; Kanbayashi T
    Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normalization of hypocretin-1 in narcolepsy after intravenous immunoglobulin treatment.
    Dauvilliers Y; Abril B; Mas E; Michel F; Tafti M
    Neurology; 2009 Oct; 73(16):1333-4. PubMed ID: 19841387
    [No Abstract]   [Full Text] [Related]  

  • 17. Normal hypocretin-1 levels in the cerebrospinal fluid of patients with fatal familial insomnia.
    Martínez-Rodríguez JE; Sanchez-Valle R; Saiz A; Lin L; Iranzo A; Mignot E; Santamaria J
    Sleep; 2003 Dec; 26(8):1068. PubMed ID: 14746394
    [No Abstract]   [Full Text] [Related]  

  • 18. Narcolepsy and low CSF orexin (hypocretin) concentration after a diencephalic stroke.
    Scammell TE; Nishino S; Mignot E; Saper CB
    Neurology; 2001 Jun; 56(12):1751-3. PubMed ID: 11425947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Narcolepsy and the hypocretins.
    Wurtman RJ
    Metabolism; 2006 Oct; 55(10 Suppl 2):S36-9. PubMed ID: 16979425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CSF hypocretin measures in patients with obstructive sleep apnea.
    Kanbayashi T; Inoue Y; Kawanishi K; Takasaki H; Aizawa R; Takahashi K; Ogawa Y; Abe M; Hishikawa Y; Shimizu T
    J Sleep Res; 2003 Dec; 12(4):339-41. PubMed ID: 14633246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.